Sevoflurane is an ether inhalation anesthetic agent used to induce and maintain general anesthesia. It is a volatile, non-flammable compound with a low solubility profile and blood/gas partition coefficient. Sevoflurane was patented in 1972, was approved for clinical use in Japan in 1990, and approved by the FDA in 1996. Sevoflurane is three times more poten...
Sevoflurane is used for the induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.
CHU Brugmann, Brussels, Belgium
Mona Mohamed Mogahed, Tanta, Elgharbia, Egypt
Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, Noord Brabant, Netherlands
Mona Mohamed Mogahed, Tanta, Elgharbia, Egypt
Shuguang Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, China
the Second Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, Jiangxi, China
Wonkwag UH, Iksan, Jeollabukdo, Korea, Republic of
Yeungnam University Medical Center, Daegu, Korea, Republic of
Sir Ganga Ram Hospital, New Delhi, Delhi, India
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.